Tag | Content |
---|
EnhancerAtlas ID | HS060-32984 |
Organism | Homo sapiens |
Tissue/cell | GM12891 |
Coordinate | chr8:11358810-11360060 |
SNPs | Number: 2 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
BCL6 | MA0463.2 | chr8:11359039-11359055 | CAGCTTTCCAGGAAAC | + | 6.02 | EN2 | MA0642.1 | chr8:11359934-11359944 | CCCAATTAGC | + | 6.02 | GFI1 | MA0038.2 | chr8:11359481-11359493 | CAAATCACTGCC | + | 6.04 | IRF1 | MA0050.2 | chr8:11359798-11359819 | TTTTTCTTTTTCTTTCTTTTT | + | 6.68 | IRF1 | MA0050.2 | chr8:11359804-11359825 | TTTTTCTTTCTTTTTTATTTT | + | 6.79 | Nr2f6(var.2) | MA0728.1 | chr8:11360015-11360030 | TGAACTCCTGACCTC | - | 6.22 | STAT1 | MA0137.3 | chr8:11359043-11359054 | TTTCCAGGAAA | + | 6.62 | Sox3 | MA0514.1 | chr8:11359716-11359726 | CCTTTGTTTT | + | 6.02 | Stat4 | MA0518.1 | chr8:11359043-11359057 | TTTCCAGGAAACAA | + | 6.53 |
|
| Number of super-enhancer constituents: 11 | ID | Coordinate | Tissue/cell |
SE_10627 | chr8:11358352-11359624 | CD19_Primary | SE_10873 | chr8:11346156-11419244 | CD20 | SE_32512 | chr8:11346599-11360078 | GM12878 | SE_55688 | chr8:11358393-11360021 | u87 | SE_58515 | chr8:11271776-11367112 | Ly1 | SE_58915 | chr8:11337047-11366620 | Ly3 | SE_60852 | chr8:11348635-11365579 | DHL6 | SE_60985 | chr8:11340629-11417326 | HBL1 | SE_61957 | chr8:11337538-11367440 | Toledo | SE_62362 | chr8:11308990-11367697 | Tonsil | SE_67747 | chr8:11358393-11360021 | u87 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr8 | 11358976 | 11359077 | chr8 | 11359368 | 11359473 |
|
Enhancer Sequence | GCCCATTTTC TTGATTTTAT TTGGTGCTTT ATGGGAAAGG CTAAACTCTC TCTCTTTTTT 60 TTTTTTTTAA CACATTAGCA TGGAAAGGAA TCATTTCTAC TTTGTGGTGT CTGTCTGTCT 120 GTCTATCTGA TGGGCTCTCT GGCACCTGCC AGCACACTGG GGGAAGTGTG AGGTCAAGAT 180 AGGCATCTTG TAGATGAAGA GCATGGCGTC CTGGTAAACG TTTAACAACC AGCTTTCCAG 240 GAAACAAATG TATTGTATAC ATACATAAGT TTATAGTAAC ATGTACTGAT ATAAAGGATG 300 CGTAGCACTT AATTTACAAA TAATAACAAA ATATGCAATA GTCTCTGTCC TAAATACCGC 360 AGAGGTGATT GAGTCTCATA GAAAGCTCTC GTGACTTTGC ACTGTCATAT CCGTAGCCAA 420 GCATTGGTTG CAGCAGATGA GCAAGTGTGG TGTTGGCACA AACACTGAAA TGTTCATTCA 480 TGTTAAGGAG CAGATCAAAG TGAAACAACA AAGAGTTGGG GCAGGCTGCA GCCTTAGTGC 540 CATGAGCGGC TTCTTTGTTG AACTGGGTAG TAGTTTTTCA ATATTCAGAA AAGTTTCCTC 600 AATGTTTTGT GCTACTCACA GTGTTCTAGC TACAGACAAG ATGCTCTTTT AAGCATAGAA 660 AATCCATGAA ACAAATCACT GCCGACCTGT AGCATTTGCC TGTTCCTGTT GTATAAATAC 720 TCCCACCAGG GCCAATTTCA AGTTGCTAAC ATGACTTGCG TGAACATGGG TTCGAGATGC 780 GCAGCAGCAC AGCACGATAG AGTACTTCCG CCTTATAGAC ACAGTCAGTT AAAGAACCTC 840 AAAGCATAGC TATTATTAAG ATGCAGTAAA AATAATCAGG AAGTGATGAG GTTTAAGTAT 900 TTATAACCTT TGTTTTAATA GAATCCATTT AGTTGTATCT TGTATAATTC AACTTTAATT 960 TTTTATCATT TTAATTTTAT ATAGTTTTTT TTTCTTTTTC TTTCTTTTTT ATTTTTCTTT 1020 GAGAAGGAGT CTTACTCTGT TGCCCAGGCT GCAGTGCAGT GGCACGATCT CTGGTCACTG 1080 CAACTTCCAC CTCCTGGGTT TAAGGGATTC TCCTGCCTCA TCCTCCCAAT TAGCTGGGAT 1140 TACAGGCACC CGCCACCATG CCTGGCTAAT TTTTGTATTT TAAGTAGAGT TAGCCAGGCT 1200 GGTCTTGAAC TCCTGACCTC AAGTGATCTG CCCAGTTCGG CCTCCCAAAC 1250
|